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Abstract
Background We assessed the clinical features and outcome
of morbidly obese patients admitted to the intensive care
unit (ICU) for management of postoperative peritonitis
(POP) following bariatric surgery (BS).
Methods In a prospective, observational, surgical ICU co-
hort, we compared the clinical features, empiric antibiotic
therapy, and prognosis of BS patients with those developing
POP after conventional surgery (cPOP).
Results Overall, 49 BS patients were compared to 134 cPOP
patients. BS patients were younger (45±10 versus 63±
16 years; p<0.0001), had lower rates of fatal underlying
disease (39 vs 64 %; p=0.002), and the same SOFA score at
the time of reoperation (8±4 vs 8±3; p=0.8) as the cPOP
patients. BS patients had higher proportions of Gram-positive
cocci (48 vs 35 %; p=0.007) and lower proportions of Gram-
negative bacilli (33 vs 44 %; p=0.03), anaerobes (4 vs 10 %;
p=0.04), and multidrug-resistant strains (20 vs 40 %; p=
0.01). Despite higher rates of adequate empiric antibiotic
therapy (82 vs 64 %; p=0.024) and high de-escalation rates
(67 % in BS cases and 51 % in cPOP cases; p=0.06), BS
patients had similar reoperation rates (53 vs 44 %; p=0.278)
and similar mortality rates (24 vs 32 %; p=0.32) to cPOP
patients. In multivariate analysis, none of the risk factors for
death were related to BS.
Conclusions The severity of POP in BS patients resulted in
high mortality rates, similar to the results observed in cPOP.
Usual empiric antibiotic therapy protocols should be applied
to target multidrug-resistant microorganisms, but de-
escalation can be performed in most cases.
Keywords Bariatric surgery .Morbidobesity .Postoperative
peritonitis . Sepsis . Multidrug-resistant bacteria . Antibiotic
adequacy . Antibiotic de-escalation
Introduction
Very few data are available concerning the clinical charac-
teristics of postoperative infections following bariatric sur-
gery (BS) in patients admitted to intensive care unit (ICU)
[1]. From the ICU physician's standpoint, this subset of
patients represents new and challenging issues and raises
specific concerns. In a group of patients referred to our ICU
with a diagnosis of postoperative peritonitis (POP), we have
previously reported delayed identification of complications,
frequently at the time of organ dysfunction [2]. In order to
identify the most relevant features in these patients, we
conducted a prospective observational study to compare
the clinical characteristics and outcome of a group of pa-
tients admitted to our ICU for POP following BS (called BS
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cases) and a group of patients who developed POP follow-
ing conventional surgery (called cPOP).
Patients and Methods
Patient Selection
The study was approved by the local institutional review
board (CEERB CHU Bichat Paris VII University, Paris),
which waived the need for signed informed consent. All
patients hospitalized in our ICU for POP between 2001 and
2011 were included in a prospective cohort database. The
diagnosis of POP was systematically assessed by reoperation
and was based on intraoperative findings, as previously de-
scribed [3]. Exclusion criteria were absence of intraoperative
samples or negative peritoneal culture. Source control was
achieved in every case.
Morbidly obese patients (body mass index (BMI)
>40 kg/m2 or >35 kg/m2 with underlying disease related to
overweight) underwent restrictive procedures (adjustable gas-
tric banding (LABG) or sleeve gastrectomy (LSG)) or Roux-
en-Y gastric bypass (RYGB).
Susceptibility Testing and Empiric Antimicrobial Therapy
Peritoneal fluid samples were systematically collected dur-
ing reoperation [3]. Gram stain for direct examination and
cultures were performed with identification and susceptibil-
ity testing. Blood cultures were drawn during the 24 h
preceding and following reoperation. Antibiotic susceptibil-
ity was determined by the disk diffusion method [4].
Multidrug-resistant bacteria (MDR) were defined as previ-
ously described [3]. Broad-spectrum antibiotics were arbi-
trarily defined as piperacillin/tazobactam (pip/taz),
imipenem (imi), and fluoroquinolones [3]. Interval antibi-
otics were defined as agents administered between the initial
surgery and reoperation, for at least 24 h and started at least
24 h before reoperation.
Our institutional protocol for parenteral empiric antibiotic
therapy (EAT) complies with the national [5] and interna-
tional [6] guidelines for the management of intraabdominal
infections. EAT is systematically initiated at the time of
reoperation, takes into account the severity of the case, and
usually combines pip/taz or imi with amikacin and vanco-
mycin possibly combined with antifungal therapy based on
presumed risk factors [7].
Data Collection
Demographic data, underlying medical condition [8], char-
acteristics of the initial surgery, antibiotic regimen, and
interval antibiotics were collected on ICU admission. In
patients who underwent BS, BMI was recorded. The
Acute Physiology and Chronic Health Evaluation II
(APACHE II) [9] and the Sequential Organ Failure
Assessment (SOFA) [10] were calculated on the day of
reoperation for POP. Organ failure (grade ≥3 of the SOFA
score) of each organ system was reported. The etiology of
POP was noted. Identification and susceptibility testing of
pathogens in blood cultures and peritoneal fluid were
recorded.
The type and duration of EAT and definitive antibiotic
therapy based on microbiologic results were recorded.
Adequacy of EAT was assessed according to susceptibility
testing, corresponding to all bacteria isolated susceptible to
at least one antibiotic administered.
De-escalation was defined as either discontinuation of an
antimicrobial agent or a change from one antibiotic to an-
other, while escalation was defined as the addition of a new
anti-infectious agent or a change of antibiotic therapy in the
opposite direction.
ICU Outcome
Time to and number of reoperations, duration of mechanical
ventilation, length of ICU stay, and ICU and in-hospital
mortality were recorded.
Statistical Analysis
Results are expressed as mean ± one standard deviation (SD)
or number and proportions. Statistical analysis used R soft-
ware (R Foundation for Statistical Computing, Vienna,
Austria). The BS group was compared with the cPOP group
using Student t-test andWilcoxon unpaired test for continuous
variables and chi-square test and Fisher's exact test for discrete
variables. A secondary exploratory within-group analysis was
also performed. Firstly, in the cPOP group, characteristics
were compared between operations performed above and
below the transverse mesocolon. Secondly, in the BS
group, characteristics were compared between restrictive
surgery and RYGB procedures. Due to its exploratory nature,
this secondary analysis did not intend to draw any definitive
conclusions.
Risk factors for mortality were analyzed. ICU survivors
and non-survivors were compared by univariate analysis.
Odds ratio (ORs) and 95 % confidence intervals (CI) were
calculated. Variables with a p-value <0.2 on univariate anal-
ysis were entered into a multivariate logistic regression
analysis with backward selection. Variables with a p-value
≥0.5 at each step of the regression analysis were rejected.
Interactions between final variables were tested and signif-
icant interactions (p<0.05) were entered in the model. The
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final model with interactions was evaluated for performance
with Nagelkerke's R2, for discrimination with the c-statistic,
and for calibration with Hosmer–Lemeshow's test. Statistical
significance was defined as p<0.05.
Table 1 Main characteristics of the two groups of patients with postoperative peritonitis following conventional and bariatric surgery expressed as
mean ± standard deviation (SD) or number (n) and proportions



















General characteristics at the time of initial surgery
Age, mean years ± SD 60±17 65±16 44±10 45±10 63±16 45±10a
Male gender, n (%) 35 (74) 51 (59) 11 (48) 8 (31) 86 (64) 19 (39)a
Underlying fatal medical condition, n (%) 25 (53) 25 (29)b – – 50 (37) –a
Immunocompromised condition, n (%) 6 (13) 11 (13) – 1 (4) 17 (13) 1 (2)c
Diabetes mellitus, n (%) 8 (17) 11 (13) 11 (48) 8 (31) 19 (14) 19 (39)a
Solid tumor, n (%) 22 (47) 33 (38) – – 55 (41) –a
Upper gastrointestinal tract surgery, n (%) 47 (100) – 23 (100) 26 (100) 47 (35) 49 (100)a
Septic or contaminated surgery, n (%) 22 (47) 38 (44) – – 60 (45) –a
Emergency procedure, n (%) 22 (47) 36 (41) – – 58 (43) –a
Curative antibiotics for initial surgery, n (%) 18 (38) 28 (32) – – 46 (34) –a
Duration of antibiotics for initial surgery,
days, mean±SD
3±3 3±4 2±3 1±1 3±4 2±2
Reoperation before transfer to our ICU, n (%) 7 (15) 20 (23) 9 (39) 12 (46) 27 (20) 21 (43)a
Interval antibiotics, n (%) 34 (72) 60 (69) 13 (57) 15 (58) 94 (70) 28 (57)
Broad-spectrum interval antibiotics, n (%) 10 (21) 26 (30) 4 (17) 9 (35) 36 (27) 13 (27)
Duration of interval antibiotics, days, mean±SD 4±2 5±3 3±2 4±6 5±3 4±4
Interval between initial surgery and reoperation,
days, mean±SD
9±9 10±7 10±7 11±11 10±8 11±9
Severity criteria at the time of reoperation
White blood cell count×103/mL, mean±SD 17±11 19±14 15±6 20±12d 18±13 18±11
SAPS II at reoperation, mean±SD 47±15 49±18 43±22 45±14 49±17 45±18
APACHE II at reoperation, mean±SD 22±7 21±8 20±9 19±8 21±7 19±8
SOFA score at reoperation, mean±SD 8±3 8±4 8±5 8±4 8±3 8±4
Hemodynamic failure, n (%) 34 (72) 61 (70) 13 (57) 18 (69) 95 (71) 31 (63)
Respiratory failure, n (%) 25 (53) 43 (49) 14 (61) 16 (62) 68 (51) 30 (61)
Renal failure, n (%) 7 (15) 22 (25) 7 (30) 15 (58) 29 (22) 22 (45)a
Neurologic failure, n (%) – 3 (3) 3 (13) – 3 (2) 3 (6)
Liver failure, n (%) 2 (4) – 1 (4) – 2 (1) 1 (2)
Hematologic failure, n (%) 4 (9) 5 (6) – – 9 (7) –
Surgical findings at reoperation
Anastomotic leak 15 (32) 27 (31) 6 (26) 19 (73)e 42 (31) 25 (51)c
Bowel perforation 14 (30) 28 (32) 14 (61) 6 (23)e 42 (31) 20 (41)
Abscesses 2 (4) 15 (17)f 3 (13) 4 (15) 17 (13) 7 (14)
Infected ascites 8 (17) 15 (17) 1 (4) 2 (8) 23 (17) 3 (6)
a Overall comparison of conventional surgery and bariatric surgery, p<0.01
b In the conventional surgery group, comparisons between above and below transverse mesocolon surgery, p<0.01
c Overall comparison of conventional surgery and bariatric surgery, p<0.05
d In the bariatric surgery group, comparisons between restrictive procedures and Roux-en-Y Gastric bypass, p<0.05
e In the bariatric surgery group, comparisons between restrictive procedures and Roux-en-Y Gastric bypass, p<0.01
f In the conventional surgery group, comparisons between above and below transverse mesocolon surgery, p<0.05
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Results
Study Population
Overall, 183 patients with POP were admitted to our
ICU, of which 32 patients (65 %) in the BS group and
49 patients (29 %) in the cPOP group underwent initial
surgery in another institution (p<0.0001). During the
study period, 554 adjustable gastric bandings, 603
sleeve gastrectomies, and 1,608 RYGB were performed
at our institution, with three deaths after sleeve gastrec-
tomy and RYGB.
Clinical characteristics on admission and at the time
of POP are shown in Table 1. The initial BS consisted
of 15 LAGB, eight LSG, and 26 RYGB. Clinical pre-
sentations were similar in BS patients who underwent
restrictive surgery or RYGB, except for a trend toward
increased proportions of renal failure in patients who
underwent RYGB (p=0.055) (Table 1). The main surgi-
cal findings at reoperation in the BS patients are
displayed in Table 1. In the group of restrictive pro-
cedures, six anastomotic leaks were identified among
patients with LSG (four repaired by suture and
lavage/drainage and one treated by drainage and endo-
scopic stent; one patient required total gastrectomy with
secondary anastomosis and feeding jejunostomy), and
13 gastric perforations were detected in patients after
LAGB, which required removal of the band with suture
of the perforation and lavage and drainage. In the
RYGB group, the majority of leaks involved the
gastrojejunal anastomosis. Overall, resection of the anastomosis
with primary reconstruction or delayed esophagojejunostomy
was performed. One patient presented stenosis of the jejuno-
jejunal anastomosis, causing perforation of the gastric remnant,
which was treated by revision of the anastomosis and total
gastrectomy.
Table 2 Micro-organisms isolated from peritoneal fluid (expressed as total number and proportions) in the two groups of patients with
postoperative peritonitis following conventional and bariatric surgery













Aerobes 113 (81) 203 (77) 40 (82) 59 (81) 316 (79) 99 (81)
Gram-positive bacteria 47 (34) 93 (35) 29 (59) 30 (41)a 140 (35) 59 (48)b
Streptococci 15 (11) 9 (3)c 20 (41) 14 (19)a 24 (6) 34 (28)b
Enterococcus spp 17 (12) 58 (22)d 2 (4) 7 (10) 75 (19) 9 (7)b
Staphylococci 14 (10) 25 (10) 5 (10) 9 (12) 39 (10) 14 (11)
Gram-negative bacteria 66 (47) 110 (42) 11 (22) 29 (40) 176 (44) 40 (33)e
Escherichia coli 19 (14) 54 (21) 3 (6) 10 (14) 73 (18) 13 (11)
Klebsiella spp 5 (4) 13 (5) 2 (4) 5 (7) 18 (4) 7 (6)
Enterobacter spp 13 (9) 13 (5) 1 (2) 3 (4) 26 (6) 4 (3)
Other Enterobacteriaceae 18 (13) 12 (5) 1 (2) 7 (10) 30 (7) 8 (7)
Non-fermenting Gram-negative bacteria 7 (5) 15 (6) 1 (2) 1 (1) 22 (5) 2 (2)
Anaerobes 5 (4) 35 (13)c 2 (4) 3 (4) 40 (10) 5 (4)e
Bacteroides spp 3 (2) 23 (9) – 2 (3) 26 (6) 2 (2)e
Fungi 21 (15) 25 (10) 7 (14) 11 (15) 46 (11) 18 (15)
Total number of micro-organisms 139 263 49 73 402 122
Monomicrobial infectionf 7 (15) 12 (14) 6 (26) 5 (19) 19 (14) 11 (22)
Presence of multidrug-resistant strainsf
Bacteremiaf 20 (43) 34 (39) 4 (17) 6 (23) 54 (40) 10 (20)e
12 (26) 21 (24) 4 (17) 4 (15) 33 (25) 8 (16)
a In the bariatric surgery group, comparisons between restrictive procedures and Roux-en-Y Gastric bypass, p<0.05
b Overall comparison of conventional surgery and bariatric surgery, p<0.01
c In the conventional surgery group, comparisons between above and below transverse mesocolon surgery, p<0.01
d In the conventional surgery group, comparisons between above and below transverse mesocolon surgery, p<0.05
e Overall comparison of conventional surgery and bariatric surgery, p<0.05
f Proportions calculated per number of patients
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Microbiologic Results
Bacteremia was reported in eight (16 %) BS patients (includ-
ing four streptococci and three Enterobacteriaceae) and
33 (25 %) cPOP patients (including eight anaerobes,
seven Enterobacter spp, and six Escherichia coli (n=6)).
A total of 122 micro-organisms were cultured from
the peritoneal fluid of BS patients, and 402 micro-
organisms were cultured from cPOP patients with a mean
number of 2.5±1.2 versus 2.9±1.4 micro-organisms, re-
spectively (p=0.03) (Table 2). Gram-positive strains rep-
resented 63 % of monomicrobial isolates of the BS
group. Mixed infections involving Gram-negative/Gram-
positive samples were observed in 12 (24 %) patients
from the BS group compared to 64 (48 %) cPOP cases
(p=0.006) (Table 2).
Eleven MDR strains were cultured from the 11 BS patients
(eight Gram-positive including seven methicillin-resistant co-
agulase negative staphylococci (MRCNS) and two
Enterobacteriaceae). A total of 73 MDR strains (35 Gram-
positive and 38 Gram-negative organisms) were cultured in
the cPOP group (one strain in 43 patients and ≥2 strains in 15)
includingMRCNS (n=24), methicillin-resistant Staphylococcus
aureus (n=6), Enterobacter spp (n=13), Pseudomonas
aeruginosa (n=9), and E. coli (n=7).
Candida albicans (n=11) was the predominant fungus
cultured in the BS group. Susceptibility to fluconazole was
confirmed in 100 % (6/6) of evaluated strains. In the cPOP
group, the most frequent fungi were C. albicans cultured in
23 (50 % of fungi) cases (12 strains susceptible to flucona-
zole) and Candida glabrata in 13 (28 %) cases (3/6 strains
resistant to fluconazole).
Table 3 Main agents used as
empiric antibiotic therapy and
definitive treatment in the two
groups of patients with
postoperative peritonitis
following conventional and
bariatric surgery expressed as
number and proportions
aOverall comparison of conven-
tional surgery and bariatric
surgery, p<0.05
bOverall comparison of conven-
tional surgery and bariatric
surgery, p<0.01









Monotherapy 37 (28) 6 (12)a 42 (31) 21 (43)
Combination therapy
Amoxicillin/clavulanic acid 3 (2) 1 (2) 20 (15) 19 (39)b
Piperacillin tazobactam 79 (59) 34 (69) 37 (28) 17 (35)
Imipenem/cilastatin 38 (28) 11 (22) 41 (31) 5 (10)b
Third-generation
cephalosporins
2 (1) – 12 (9) –a
Vancomycin 50 (37) 19 (39) 39 (29) 19 (39)a
Aminoglycosides 58 (43) 31 (63)a 18 (13) 6 (12)
Fluoroquinolones 11 (8) 2 (4) 12 (9) 2 (4)
Metronidazole 6 (4) 2 (4) 25 (19) 3 (6)a
Fluconazole 39 (29) 23 (47)a 41 (31) 19 (39)
Table 4 Mortality and morbidity criteria in patients with postoperative peritonitis following conventional and bariatric surgery. Results are



























Inadequate empiric antibiotic therapy, n (%) 24 (51) 62 (71)a 3 (13) 6 (23) 86 (64) 9 (18)b
Duration of antibiotic therapy, days, mean±SD 12±6 10±4a 11±5 10±3 11±5 11±4
Reoperation, n (%) 20 (43) 39 (45) 12 (52) 14 (54) 59 (44) 26 (53)
Duration of mechanical ventilation, days, mean±SD 14±15 8±10a 13±12 13±12 10±12 13±12
Death, n (%) 15 (32) 28 (32) 6 (26) 6 (23) 43 (32) 12 (24)
Duration of ICU stay, days, mean±SD 21±15 18±16 18±15 23±19 19±15 20±17
a In the conventional surgery group, comparisons between above and below transverse mesocolon surgery, p<0.05
b Overall comparison of conventional surgery and bariatric surgery, p<0.05
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Antibiotic Therapy
At the time of reoperation for POP, EAT was initiated in all
cases (Table 3). Monotherapy was administered to only a
limited number of cases and mainly consisted of pip/taz (six
BS patients and 32 cPOP patients). A total of 84 organisms
were not adequately treated by EAT. Inadequacy of combi-
nation therapy was observed in seven (14 %) BS patients
and 32 (24 %) cPOP patients. Presence of MDR strains was
an important factor of inadequacy: six MDR strains were
reported in six of the nine (66 %) BS patients and 41 MDR
strains were reported in 32 (66 %) cPOP patients with
inadequate EA therapy.
Poor clinical response and/or susceptibility testing led to
escalation therapy in three (6 %) BS patients versus 31 (23 %)
cPOP patients (p=0.009) at the time of definitive antibiotic
therapy. De-escalation was performed in 33 (67 %) BS cases
and 69 (51 %) cPOP cases (p=0.06).
Table 5 Univariate analysis of outcome at discharge from intensive care unit, expressed as mean ± standard deviation or total number (%)




p-value Odd ratios 95 % confidence
intervals
Gender (male) 0 32 (58) 73 (57) 1 1.048 0.554–2.001
Age (year) 0 62±15 56±18 0.019 1.022 1.002–1.043
Ultimately/rapidly fatal underlying diseasea 0 16 (29) 34 (27) 0.721 1.134 0.553–2.267
Solid tumor 0 14 (25) 42 (33) 0.383 0.699 0335–1.399
Type 1 diabetes mellitus 0 14 (25) 24 (19) 0.324 1.479 0.685–3.112
Initial emergency surgery 0 26 (47) 32 (25) 0.005 2.689 1.386–5.249
Initial surgery 0 0.649
Below transverse mesocolon 20 (36) 53 (41) 1 –
Above transverse mesocolon 15 (27) 38 (30) 1.046 0.470–2.296
Combined 20 (36) 37 (29) 1.432 0.676–3.042
Bariatric surgery 0 12 (22) 37 (29) 0.366 0.686 0.315–1.416
Contaminated or septic initial surgeryb 0 18 (33) 43 (34) 1 0.961 0.484–1.868
Reoperation before transfer to our unit 0 11 (20) 37 (29) 0.271 0.614 0.276–1.286
Ongoing antibiotic therapyc 0 33 (60) 74 (58) 0.870 1.094 0.577–2.100
Time to reoperation 2 10±9 10±8 0.572 0.996 0.955–1.034
SAPS II score 0 60±18 42±14 <0.0001 1.084 1.055–1.118
APACHE II score 0 26±6 19±7 <0.0001 1.200 1.131–1.286
SOFA score 0 11±3 7±3 <0.0001 1.504 1.316–1.763
Hemodynamic failure 0 46 (84) 80 (63) 0.005 3.066 1.432–7.193
Respiratory failure 0 37 (67) 61 (48) 0.016 2.257 1.178–4.447
Coagulation failure 0 7 (13) 2 (2) 0.003 9.187 2.133–63.143
Liver failure 0 2 (4) 1 (1) 0.215 4.792 0.449–104.429
Renal failure 0 21 (38) 23 (18) 0.005 2.819 1.389–5.744
Bacteremia 0 16 (29) 25 (20) 0.177 1.690 0.806–3.483
Polymicrobial infection 0 45 (18) 108 (16) 0.668 0.833 0.368–1.985
Infection involving Enterobacter spp 0 12 (22) 17 (13) 0.185 1.822 0.789–4.111
Infection involving enterococci 0 28 (51) 47 (37) 0.101 1.787 0.943–3.401
Infection involving streptococci 0 6 (11) 41 (32) 0.003 0.259 0.093–0.614
Concomitant fungal infection 0 22 (40) 40 (31) 0.307 1.466 0.756–2.822
Infection involving multidrug-resistant organisms 0 16 (29) 48 (38) 0.313 0.683 0.338–1.336
Adequate empiric therapyc 0 37 (67) 89 (70) 0.862 0.900 0.460–1.796
Persistent sepsis 0 48 (87) 45 (35) <0.0001 12.647 5.592–32.715
Subsequent reoperation 0 38 (69) 47 (37) <0.0001 3.852 1.988–7.718
SAPS simplified acute physiology score, SOFA sepsis-related organ failure assessment
a Classification of McCabe and Jackson (14)
b Polk/Altemeier classification
c At the time of diagnosis of postoperative peritonitis
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At the time of definitive therapy, monotherapy mainly
consisted of amoxicillin/clavulanic acid in BS patients (12
(24 %) patients), while in the cPOP group, monotherapy was
based on amox/clav (n=15, 11 %), pip/taz (n=14, 10 %), or
imi (n=8, 6 %). Overall, amox/clav represented 34 (69 %) of
all definitive therapies in BS cases. Antifungal therapy, mainly
fluconazole, was given in 21 (43%) BS patients and 46 (34%)
cPOP cases (Table 3).
Patient Outcome
Following the first reoperation in our institution, 19 (39 %)
BS patients and 75 (56 %) cPOP patients had a favorable
outcome (p=0.04) (Table 4). A total of 12 (24 %) BS
patients and 43 (32 %) cPOP patients died (p=0.32) after
a mean interval of 17±16 vs 21±16 days, respectively
(p=0.37). No significant difference was observed between
BS patients treated by restrictive surgery or RYGB.
The risk factors for death identified on univariate analysis
are presented in Table 5. The BS variable was forced into the
multivariate logistic regression analysis model. No significant
interaction was observed between the final variables. On
multivariate analysis, four criteria were significantly associat-
ed with outcome, but none of them were specifically linked to
BS (Table 6).
Discussion
To the best of our knowledge, our results provide a unique
picture of patients who develop POP following BS. These BS
patients represent an atypical group that differs from cases of
cPOP or cannot be considered to be similar to patients with
complicated upper mesocolic surgery. Our highly selected
population and the observational study design could be con-
sidered to be poorly representative of the complications of BS
as most of these complicated cases are treated in surgical
wards. We nevertheless assume that this global analysis could
provide general conclusions that could be applied to all com-
plicated cases of BS in the ICU setting, although RYGB
appears to present a number of specificities. In addition, our
recruitment does not reflect the local incidence of these com-
plications. Consequently, we cannot provide a clear estimate
of the proportion of BS patients requiring ICU admission.
In studies reporting cPOP patients admitted to the ICU, the
proportions of upper mesocolic cases usually ranged between
13 and 30 % of cases [11–14]. While leak rates are close to
zero in the postoperative course of gastric banding [15–17],
rates as high as 20 % have been observed after RYGB. Recent
publications report mortality rates after anastomotic leaks
ranging between 6 and 22 % [18–20] and up to 66 % in some
series [21, 22] of RYGB. The delayed diagnosis of these leaks
following BS ranges between 1 and 18 days [23] as they are
frequently asymptomatic or associated with limited clinical
signs [18, 23, 24]. This paucity of symptoms has been previ-
ously reported in ICU cases [2]. The large number of
reoperations performed before transfer to our institution sug-
gests that the postoperative complication was diagnosed early
in many cases. However, technical issues and recurrent or
persisting infections justified transfer of a large number of
cases.
Polymicrobial infections and prior antibiotic usage are
common in the course of POP and may create a bias in the
samples retrieved. The high frequency of Gram-positive
cocci and fungi reported in BS cases is not surprising as it
has been previously observed in patients with gastroduode-
nal or upper mesocolic perforations, including cPOP cases
[25]. The microbiologic characteristics of patients who
underwent complicated RYGB have not been previously
studied. Our results suggest that these patients should be
considered as having small bowel perforation rather than
upper gastrointestinal perforation, but the overall ICU clin-
ical management does not appear to be different from that
applied to restrictive BS cases. High concentrations of aer-
obes, anaerobes, and fungi have been reported in the stom-
ach flora of patients undergoing bypass for morbid obesity
[26]. The high pH reported in these patients is also a
predisposing factor to yeast growth [26]. The prior use of
antibiotic therapy before the diagnosis of POP is a major
risk factor for the emergence of MDR strains and fungi. This
Table 6 Multivariate analysis (with backward selection but similar results with forward and stepwise selection)




Initial emergency surgery 3.963 1.586–10.576 0.0130
APACHE II score (per 1 point increase) 1.177 1.096–1.276 <0.0001
Infection involving streptococci 0.316 0.097–0.916 0.0088
Persistent sepsis 11.241 4.336–33.532 <0.0001
Nageelkerke R2 0.54 0.515
c-statistic 0.89 0.88
Hosmer–Lemeshow test 0.68
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risk of MDR strains justifies the use of EAT protocols
comprising broad-spectrum agents [3]. Interestingly, the
overall proportion of MDR strains remains low in BS cases
and allows de-escalation therapy in most cases [3]. These
observations are helpful to guide EAT and suggest that
complicated BS patients are at moderate risk for harboring
MDR strains and at high risk of fungal infection. Based on
the candida peritonitis score [7], our local protocol recom-
mends early antifungal therapy in these patients. This com-
bined approach allows an acceptable adequacy of 80 % of
all empiric therapy in BS cases, much higher than that
observed in cPOP patients.
Recent studies have reported contradictory results on the
prognosis of morbidly obese patients admitted to the ICU,
from a decreased risk of in-hospital mortality in surgical
patients [27] to increased morbidity in a mixed population
[28] and even an increased risk of death among surgical
patients [29]. When compared to BS cases treated conserva-
tively, in whom no death is reported, the patients who require
reoperation have high mortality rates of up to 18 to 22 % [24,
30], and even to 40 % in some specific subpopulations [31].
Despite their younger age and a low incidence of underlying
disease, our BS patients demonstrated similar levels of sever-
ity, and even higher initial rates of renal failure than cPOP
patients. This point suggests that these patients should be
considered to be at high risk of complications and death,
although BS did not appear to be a significant risk factor for
mortality on multivariate analysis.
Conclusion
The present data suggest that, despite a younger age, the
severity of POP following BS results in high mortality rates,
similar to those observed in older patients with cPOP. The
usual empiric antibiotic therapy protocols should be applied
because of the potential risk of MDR strains, but de-escalation
can be performed in most cases.
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